

Publisher: Bentham Science Publishers
E-ISSN: 1873-5576|14|7|621-637
ISSN: 1568-0096
Source: Current Cancer Drug Targets, Vol.14, Iss.7, 2014-09, pp. : 621-637
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Evidences have demonstrated key mediatory roles of microRNA-205 (miR-205) in normal physiology and its aberrant expression in many cancers. Indeed, miR-205 has been identified as both a tumour suppressive and oncogenic miRNA playing crucial roles in tumourigenesis through regulating different cellular pathways such as cell survival, apoptosis, angiogenesis and metastasis. As a tumour suppressor, miR-205 acts as an inhibitor of cell proliferation, migration and invasion. On the other hand, as an oncogene, miR-205 promotes tumour initiation and development. All these functions act through different target genes in various types of cancers. Also, miR-205 displays potential as a therapeutic target for different cancers. To conclude, miR-205 has important clinical and pathological correlations in different cancers and may act as a diagnostic and prognostic marker as well as new molecular target for cancer therapy.
Related content


miR-210: a therapeutic target in cancer
By Hong Liu Han Yu Zhang Hongwei Zhao Qingchuan Qiao Yuan
Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 1, 2013-01 ,pp. :


miR-149 as a Potential Molecular Target for Cancer
Current Medicinal Chemistry, Vol. 25, Iss. 9, 2018-03 ,pp. :



